Ortho-Cept

This page contains recent news articles, when available, and an overview of Ortho-Cept but does not offer medical advice. You should contact your physician with regard to any health issues or concerns.

Overview:

Ortho-Cept (when available)

Pharmacology and use:
Ethinyl estradiol is a synthetic derivative of the natural estrogen estradiol. It is one of two estrogens currently used in oral contraceptive pills. The other, mestranol, is converted to ethinyl estradiol before it is biologically active. Ethinyl estradiol and norethindrone are used together as an oral contraceptive agent. For treatment of moderate to severe vasomotor symptoms associated with the menopause, female hypogonadism, prostatic carcinoma-palliative therapy of advanced disease, breast cancer, as an oral contraceptive, and as emergency contraceptive.

Mechanism Of Action:
Estrogens diffuse into their target cells and interact with a protein receptor. Target cells include the female reproductive tract, the mammary gland, the hypothalamus, and the pituitary. Estrogens increase the hepatic synthesis of sex hormone binding globulin (SHBG), thyroid-binding globulin (TBG), and other serum proteins and suppress follicle-stimulating hormone (FSH) from the anterior pituitary. The combination of an estrogen with a progestin suppresses the hypothalamic-pituitary system, decreasing the secretion of gonadotropin-releasing hormone (GnRH).

News Articles on Ethinyl Estradiol

Petition seeks ban on desogestrel; blood clots cited  -  Feb 7, 2007
By Rita Rubin. A consumer group petitioned the Food and Drug Administration Tuesday to ban oral contraceptives that contain the synthetic hormone ... USA Today

acceptable | Definition of acceptable | HighBeam.com: Online Dictionar...  -  Jul 12, 2006
Find out what acceptable means: The Oxford American College Dictionary has the definition of acceptable. Research related newspaper, magazine, ... Pay-Per-View - Oxford American College Dictionary - HighBeam Research

FINDINGS  -  Feb 7, 2007
The findings were more bad news for Trasylol: The same scientists found the drug raised the risk of kidney failure, heart attacks and strokes in a study ... Pay-Per-View - Washington Post - ProQuest Archiver

Article: Greening of the grass brings out killer instinct. - Spokesman...  -  Apr 15, 2006
Greening of the grass brings out killer instinct. ... find Spokesman-Review (Spokane, WA) articles. Byline: Jim Kershner Apr. 15--We were standing there in ... Pay-Per-View - Spokesman-Review - HighBeam Research

Watson Pharmaceuticals Receives FDA Approval for Desogestrel and …  -  Aug 1, 2005
CORONA, Calif., Aug. 1 /PRNewswire-FirstCall/ -- Watson Pharmaceuticals, Inc. , a leading specialty pharmaceutical company, announced today that it has ... RedOrbit

Press Release: Watson Pharmaceuticals Receives FDA Approval for …  -  Aug 1, 2005
Watson Pharmaceuticals Receives FDA Approval for Desogestrel and Ethinyl Estradiol Tablets USP, 0.15MG / 0.03MG. from PR Newswire. Pay-Per-View - PR Newswire - HighBeam Research

Article: Hi-tech advances offer a better view ahead.(Features) -...  -  Sep 24, 2007
Hi-tech advances offer a better view ahead.(Features) ... find Western Mail (Cardiff, Wales) articles. Byline: By Madeleine Brindley Western Mail ... Pay-Per-View - Western Mail - HighBeam Research

Excerpt: 'Why My Wife Thinks I'm an Idiot'  -  Jun 12, 2006
As host of ESPN's hugely popular radio show "Mike & Mike in the Morning," Mike Greenberg has interviewed everyone from Michael Jordan to Danica Patrick. ... ABC News

Pressing to Look Closer at Blood Clots and the Pill  -  Feb 13, 2007
By MICHAEL MASON. At every exit sign that whizzed past, Kathleen Biggins wondered if she should turn off the Saw Mill River Parkway and call for help. ... New York Times

finger on the pulse  -  Feb 16, 2007
Researchers studied 61208 births in Ontario during 2005, including 1394 that resulted from fertility treatments. Nearly 3 per cent of fertility-assisted ... Pay-Per-View - Toronto Star - ProQuest Archiver

Lawsuit: Organon's Nuvaring caused young mom's deadly blood clot  -  Mar 20, 2008
AP. TRENTON, NJ - The widower of a New Jersey woman who died suddenly while using the NuvaRing contraceptive is suing its maker, claiming the device caused ... phillyBurbs.com

Event Brief of Q3 2005 Watson Pharmaceuticals, Inc. Earnings …  -  Nov 2, 2005
PARTICIPANTS . Patty Eisenhaur, Watson Pharmaceuticals, Inc., Director-IR . Dr. Allen Chao, Watson Pharmaceuticals, Inc., Chairman, CEO . ... Free with registration - America's Intelligence Wire - AccessMyLibrary.com

�?��?�?�孕�?��?�致血�?丧命患心�?病妇女�?宜使用  -  Feb 7, 2007
...�?�美国媒体北京时间今晨报�?�，一些美国消费者团体上书FDA(美国食�?�?�物监�?�管�?�局) 呼�??�?止销售目�?市场上的低剂�?�?��?�?�孕�?�，因其�?�能导致妇女血�?，甚至致命。 ... 中新网

New generics.(drug approvals)  -  Oct 24, 2005
Danazol capsules have been approved for Pheladelphia-based Lannett Co., (215) 33309000. Danazol, a gonadotropin inhibitor and sex hormone, ... Free with registration - Drug Topics - AccessMyLibrary.com

第三代�?�孕藥致血栓，美國�?�售�?�浪高  -  Feb 8, 2007
...〔編譯鄭寺音�?記者胡清暉�?綜�?�報導〕美國消費者權利促進團體「公共市民�?（Public Citizen），六日�?�美國食�?暨藥物管�?�局（ＦＤＡ）�?�交請願書，�?求ＦＤＡ�?止血栓 ... 自由時報

2. Jeep Promo Opens Online Comic Plot To Consumers by Karl …  -  Feb 9, 2007
...by Sarah Mahoney. "Think locally" may be the mantra for many of Whole Foods' environmentally-conscious customers, but at the moment, it's backfiring--at ... Mediapost.com

New generics.  -  Oct 24, 2005
New generics. Danazol capsules have been approved for Pheladelphia-based Lannett Co., (215) 33309000. Danazol, a gonadotropin inhibitor and sex hormone, ... $9.94 - Drug Topics - Alacra Store

Watson Pharmaceuticals.  -  Sep 26, 2005
Watson Pharmaceuticals. Watson Pharmaceuticals last month received final approval from the FDA on its application for desogestrel and ethinyl estradiol ... $9.94 - Drug Store News - Alacra Store

Nader's Public Citizen Taps YouTube For Lobbying Effort  -  Feb 9, 2007
...by Christine Bittar, Friday, February 9, 2007, 6:00 AM. Watchdog consumer advocacy group Public Citizen is using YouTube for the first time to spread its ... MediaPost Publications

Steroidal hormones for contraception in women with sickle cell disease  -  May 4, 2007
Hormonal contraceptives are unlikely to predispose women to type 2 diabetes and appear to be safe for those with sickle cell anemia. ... News-Medical.net

Watson�?�孕�?�获得FDA许�?�  -  Aug 1, 2005
...�?MarketWatch纽约8月1日讯】Watson Pharmaceuticals Inc.(WPI)表示，其去氧孕烯与乙炔雌二醇片剂已获得美国食�?与�?�物管�?�局(FDA)批准。 ... 新浪网

Health Matters: A day in the life of a hospital  -  Feb 7, 2007
What goes on inside the walls of a hospital? If today is a typical Thursday at Union Hospital, Kristi Roshel, its marketing and public relations manager, ... Terre Haute Tribune Star

Accused Astronaut Arrives Back in Houston; US Helicopter Down in...  -  Feb 7, 2007
MONROE: Well, it's pretty hard to get a waiver if you're a felon. If you have a misdemeanor, you need a waiver. But, I mean, if you're a felon, you know, ... Free with registration - America's Intelligence Wire - AccessMyLibrary.com

More expensive birth control spurs frustration  -  Mar 19, 2007
For example, brand name Ortho-Cept is $56.99 while Apri, its generic brand, is only $29.09, according to CVS Pharmacy, 116 W. College Ave. ... psu.edu

Press Release: Duramed Announces Canadian Approval of SEASONALE …  -  Jul 5, 2007
Duramed Announces Canadian Approval of SEASONALE(R) Extended-Cycle Oral Contraceptive. from PR Newswire. Highbeam Research – FREE Trial. Pay-Per-View - PR Newswire - HighBeam Research

Petizione dell'FDA per il ritiro dal mercato dei contraccettivi orali...  -  Apr 18, 2007
Mercoledì18 Aprile 2007 - Public Citizen, un'organizzazione di consumatori statunitense, ha inviato una petizione all'FDA ( Food and Drug Administration ) ... XagenaSalute

Brand Names/Synonyms:
Ortho-Cept is also known by the following brand names and/or synonyms17?-Ethynylestradiol; 17alpha-Ethinylestradiol; 17alpha-Ethynylestradiol; 17alpha-Ethynyloestradiol; Aethinyloestradiolum; Aethinyoestradiol [German]; Alesse; Alora; Amenoron; Amenorone; Anovlar; BRN 2419975; Binovum; Brevicon; Brevinor; CCRIS 286; CHEMBANK1139; Climara; Conceplan; Cyclosa; Demulen; Desogen; Dicromil; Diognat-E; Diogyn E; Diogyn-E; Diprol; Dyloform; EE; EE2; EO; ETHINYLESTRADIOL; Ertonyl; Esclim; Esteed; Estigyn; Estinyl; Eston-E; Estopherol; Estoral; Estoral {[Orion]}; Estorals; Estrace; Estraderm; Estradiol; Estring; Estrogel; Estrogen; Ethidol; Ethinoral; Ethinyl Estradiol; Ethinyl-Oestranol; Ethinylestradiolum [Inn-Latin]; Ethinylestriol; Ethinyloestradiol; Ethy 11; Ethynylestradiol; Ethynyloestradiol; Eticyclin; Eticyclol; Eticylol; Etinestrol; Etinestryl; Etinilestradiol [Inn-Spanish]; Etinilestradiolo [Dcit]; Etinoestryl; Etistradiol; Etivex; Feminone; Fempatch; Follicoral; Genora; Ginestrene; Gynodiol; Gynolett; HSDB 3587; Halodrin; Inestra; Innofem; Jenest; Kolpolyn; Levlen; Linoral; Lo/Ovral; Loestrin; Logynon; Lynoral; Marvelon; Menolyn; Menostar; Mercilon; Microfollin; Microgynon; Mircette; Modicon; NEE; NSC-10973; Necon; Nelova; Neo-Estrone; Neocon; Nogest-S; Norcept; Nordette; Norethin 1/35 E; Norimin; Norinyl; Norlestrin; Novestrol; Oradiol; Orestralyn; Orestrayln; Ortho Tri-Cyclen; Ortho-Cept; Ortho-Cyclen; Ortho-Novum; Ovcon; Ovex; Oviol; Ovral; Ovran; Ovranette; Ovysmen; Palonyl; Perovex; Primogyn; Primogyn C; Primogyn M; Progynon C; Progynon M; Prosexol; Spanestrin; Stediril; Synphase; Tetragynon; Thiuram E; Thiuranide; Tri-Levlen; Tri-Norinyl; Trinordiol; Trinovum; Triphasil; Vagifem; Varnoline; Vivelle; Ylestrol

Drug Category:
Ortho-Cept is categorized under the following by the FDA: Estrogens; ATC:G03CA01

Dosage Forms:
DISC (SUSTAINED-RELEASE); GEL; IMPLANT; LIQUID; PATCH; RING (SLOW-RELEASE); SOLUTION; TABLET

Absorption:
Rapid and complete absorption follows oral intake of ethinyl estradiol (bioavailability 43%).

Interactions:
[an error occurred while processing this directive]

Chemical IUPAC Name:
17-ethynyl-13-methyl-7,8,9,11,12,13,14,15,16,17-decahydro-6H-cyclopenta[a]phenanthrene-3,17-diol

Disclaimer:

Contact a physician with regard to health concerns. Email requests for further health information will be discarded.

The materials contained on this Web site are for informational purposes only and do not constitute health or medical advice. Use of information on this site does not create or constitute any kind of agreement or contract between you and the owners or users of this site, the owners of the servers upon which it is housed, or anyone else who is in any way connected with this site.

Many links on cancernewsnetwork.org lead to other sites. cancernewsnetwork.org does not sponsor, endorse or otherwise approve of the materials appearing in such sites. Nor is CancerNewsNetwork.org responsible for dead or misdirected links.

IF YOU NEED A LINK OR TEXT REMOVED FROM THIS PAGE PLEASE CONTACT cancernewsnetwork (at) live.com.
We will do our best to accommodate your request.